p21(WAF) is a cyclin-dependent kinase inhibitor which is widely expressed i
n epidermal structures. Using a combination of double immunocytochemical st
aining and combined ill situ hybridization. we show that there is a strikin
g exclusivity between the expression of Ki67 and p21(WAF) in the hair matri
x. Some cells that are Ki67-positive also express p53, but as they exit the
cell cycle they assume p21(WAF)-positive/p53-negative status. By contrast,
cells in the interfollicular epidermis of psoriatic lesions, in the sebace
ous gland, and in the outer root sheath are p21(WAF)-positive/p53-positive
but Ki67-negative. These results suggest that in some anatomical parts of t
he epidermis, p21(WAF) expression can accompany p53 expression, whereas in
other parts, the expression of these markers is reciprocal, suggesting that
other pathways may he controlling p21WAF expression. In order to define, f
unctionally, the presence of p53-independent p21(WAF) expression in skin, w
e examined lesions of Bowen's disease in which both alleles of p53 were ina
ctivated. p21(WAF) expression was still observed, confirming a role for p53
-independent expression of p21(WAF) in human skin in vivo.